| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3437796 | American Journal of Obstetrics and Gynecology | 2009 | 10 Pages |
Abstract
The CA125 YTLDrDSLYV peptide is an immunogenic epitope and may represent an attractive target for immunotherapy of ovarian cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Stefania PhD, Simone PhD, Timothy J. PhD, Martin J. PhD, Dan-Arin MD, Masoud MD, Peter E. MD, Thomas J. MD, Sergio MD, Alessandro D. MD,